cvs health glp-1 receptor agonist weight management diabetes treatments Today, we released promising data from the program, in which participants achieved more than 15% weight loss on average, including existing users of anti-obesity… GLP-1 Resource Center
Description
Further, the recent announcements will not impact costs for Medicaid enrollees as they already pay little or no copays for prescription drugs, and the costs of purchasing drugs directly from manufacturers through TrumpRx will likely still be prohibitive for people on Medicaid who must have a low income to qualify for the program
Cost-effectiveness assessments demonstrate significant variability across healthcare systems and patient demographics
[DOI] [PMC free article] [PubMed] [Google Scholar] 91
Gong et al., 2024)
